Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day
    • DocsApp raises 7.2...

    DocsApp raises 7.2 million dollars from Bessemer Venture Partners, others

    Written by Ruby Khatun Khatun Published On 2017-12-14T10:53:57+05:30  |  Updated On 14 Dec 2017 10:53 AM IST
    DocsApp raises 7.2 million dollars from Bessemer Venture Partners, others

    New Delhi: Health-tech startup DocsApp said it has closed a funding round of USD 7.2 million from Bessemer Venture Partners (BVP) and Japanese investors TechMatrix Corporation and DeNA networks.


    Existing Facebook angel investors Anand Rajaraman, Venky Harinarayan and Japanese VC Rebright partners also participated in the series A round, the company said in a statement.




    The capital infusion will be leveraged towards team expansion, business growth and building up the company's tech backbone, it added.


    Using DocsApp's platform, patients can connect with specialist doctors - across 18 different specialties - for consultations via chat or call through its mobile app.


    Investment banking firm Masterkey Holdings acted as the sole financial advisor to DocsApp for the transaction.


    DocsApp co-founder and CEO Satish Kannan said the company wants to bridge the gap between patients and specialist doctors through its platform so that people can get expert and personalized consultations on demand.


    "We believe that the new round of funding will help us take specialized care downstream to more remote and underpenetrated areas across the country," he added.


    He said about 40 percent of the total consultations on its platform come from rural parts of the country.


    "...we serve over 50,000 patients every month, by the coming year we aim to serve over 3,00,000 patients in a month and our overall vision is to make DocsApp synonymous with a trusted platform to get authentic medical advice easily over the mobile for patients," he added.


    Founded in 2015 by IIT Madras alumni Satish Kannan and Enbasekar Dinadayalane, the Bengaluru-based firm has raised a total of USD 8.4 million till date.


    It supports 18 specialties such as gynaecology, psychiatry, dermatology, cardiology, oncology, among others.


    DocsApp aims to touch 100 million patients in the next five years across India and Southeast Asia.

    Anand RajaramanBessemer Venture PartnersDeNA networksDocsAppdoctorsFacebookFund raisefund raisingfundingHealth-techInvestmentJapanese investorsMasterkey HoldingsRaisesSatish KannanstartupTechMatrix CorporationVenky Harinarayan
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok